Plasma Supply Falling Behind Demand: Kristopher Jonas Sounds the Alarm
Kristopher Jonas, CEO/President of Proesis Biologics, posted on LinkedIn:
”You know what’s scary?
The growing gap between how much plasma-derived medicine the world needs and how much plasma we’re actually collecting.
Global demand for immunoglobulins (IG) continues to climb 6–8% each year. And that’s not even factoring in underutilization in low to middle-income countries.
Fractionators are bringing new manufacturing capacity online across the U.S. and Europe.
But all that capacity still depends on one thing – human plasma – and the supply side isn’t keeping pace.
That’s where independent collectors come in.
We’re the flexible link in the chain, able to expand quickly, reach new donor communities, and help ensure the growing global infrastructure doesn’t sit idle waiting for plasma.
Not spooky. Just real.
And it’s why what we’re building at Proesis Bio matters.”
Keep up with Hemostasis Today.
-
Jul 8, 2026, 16:58Emmanuel J Favaloro։ Acquired von Willebrand Syndrome: Key Concepts for Clinical Practice
-
Jul 8, 2026, 16:47Arun V. J: Why Healthcare Professionals Need More Than Medical Training
-
Jul 8, 2026, 16:38Mona Alfaraj: What Does This HbA₂ Pattern Suggest?
-
Jul 8, 2026, 16:34Alexandros Tsourpas: One of CIMB’s Top-Performing Papers of 2025
-
Jul 8, 2026, 16:27Jan Sloves: Medial Thigh Perforators – The Veins We Keep Missing
-
Jul 8, 2026, 16:23William Aird: A Basic Architecture of Hematology
-
Jul 8, 2026, 16:09Abdulrahman Katib: New Leadership for Better VTE Care
-
Jul 8, 2026, 16:09Does MPN Change the Outlook After Splanchnic Vein Thrombosis? – JTH
-
Jul 8, 2026, 16:01Marianne Yee: The Results of RBC Transfusion Survival Studies